Nurix Therapeutics' Chief Financial Officer, Hans van Houte, sold a total of 14,055 shares of common stock on May 5, 2026, through two open-market tra...
Neutral
Nurix Therapeutics CFO Houte Hans Van sold 2,388 shares of NRIX stock to cover tax withholding obligations, reducing his stake by 4.42%. Despite the c...
Neutral
Gwenn Hansen, CSO of Nurix Therapeutics (NASDAQ:NRIX), sold 3,214 shares worth $53,497 to cover tax obligations from RSU vesting on April 30, 2026. Th...
Nurix Therapeutics' Chief Scientific Officer, Gwenn Hansen, recently converted restricted stock units (RSUs) into 8,608 shares of common stock. On the...
Nurix Therapeutics' CFO, Hans van Houte, reported that 8,608 restricted stock units (RSUs) vested on April 30, 2026. To cover tax withholding obligati...
Nurix Therapeutics CFO Hans van Houte sold 2,388 shares worth $39,748 to cover tax obligations from vested restricted stock units, not due to discreti...